1. Home
  2. MAGN vs DNA Comparison

MAGN vs DNA Comparison

Compare MAGN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnera Corporation

MAGN

Magnera Corporation

N/A

Current Price

$11.45

Market Cap

424.7M

ML Signal

N/A

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

N/A

Current Price

$6.95

Market Cap

458.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAGN
DNA
Founded
1864
2008
Country
United States
United States
Employees
2980
N/A
Industry
Paper
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
424.7M
458.6M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MAGN
DNA
Price
$11.45
$6.95
Analyst Decision
Hold
Hold
Analyst Count
1
2
Target Price
$12.00
$8.50
AVG Volume (30 Days)
342.9K
1.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.64
46.49
EPS
N/A
N/A
Revenue
$3,204,000,000.00
$170,155,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
$3.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.50
N/A
52 Week Low
$7.82
$5.37
52 Week High
$15.52
$17.58

Technical Indicators

Market Signals
Indicator
MAGN
DNA
Relative Strength Index (RSI) 40.52 42.08
Support Level $11.64 $6.38
Resistance Level $12.96 $7.10
Average True Range (ATR) 0.46 0.34
MACD -0.07 0.02
Stochastic Oscillator 20.51 17.57

Price Performance

Historical Comparison
MAGN
DNA

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: